1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 OBJECTIVES OF THE STUDY
2.2 STAKEHOLDERS
2.3 DATA SOURCES
2.3.1 PRIMARY SOURCES
2.3.2 SECONDARY SOURCES
2.4 MARKET ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 TOP-DOWN APPROACH
2.5 FORECASTING METHODOLOGY
3 EXECUTIVE SUMMARY
4 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - INTRODUCTION
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.3 INDUSTRY TRENDS
4.4 COMPETITIVE INTELLIGENCE
5 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET LANDSCAPE
5.1 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
5.2 MARKET FORECAST (2025-2033)
6 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - BY PRODUCT TYPE
6.1 ARTIFICIAL ORGAN
6.1.1 OVERVIEW
6.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
6.1.3 MARKET SEGMENTATION
6.1.3.1 ARTIFICIAL HEART
6.1.3.2 ARTIFICIAL KIDNEY
6.1.3.3 ARTIFICIAL LUNGS
6.1.3.4 COCHLEAR IMPLANTS
6.1.3.5 OTHERS
6.1.4 MARKET FORECAST (2025-2033)
6.2 BIONICS
6.2.1 OVERVIEW
6.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
6.2.3 MARKET SEGMENTATION
6.2.3.1 VISION BIONICS
6.2.3.2 CARDIAC BIONICS
6.2.3.3 ORTHOPEDIC BIONIC
6.2.3.4 OTHERS
6.2.4 MARKET FORECAST (2025-2033)
7 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - BY TECHNOLOGY
7.1 MECHANICAL BIONICS
7.1.1 OVERVIEW
7.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
7.1.3 MARKET FORECAST (2025-2033)
7.2 ELECTRONIC BIONICS
7.2.1 OVERVIEW
7.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
7.2.3 MARKET FORECAST (2025-2033)
8 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - BY METHODS OF FIXATION
8.1 EXTERNALLY WORN
8.1.1 OVERVIEW
8.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
8.1.3 MARKET FORECAST (2025-2033)
8.2 IMPLANTABLE
8.2.1 OVERVIEW
8.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
8.2.3 MARKET FORECAST (2025-2033)
9 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - BY APPLICATION
9.1 CLINICAL RESEARCH INSTITUTIONS
9.1.1 OVERVIEW
9.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
9.1.3 MARKET FORECAST (2025-2033)
9.2 HOSPITALS
9.2.1 OVERVIEW
9.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
9.2.3 MARKET FORECAST (2025-2033)
10 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET – BY REGION
10.1 KANTO REGION
10.1.1 OVERVIEW
10.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.1.3 MARKET BREAKUP BY PRODUCT TYPE
10.1.4 MARKET BREAKUP BY TECHNOLOGY
10.1.5 KEY PLAYERS
10.1.6 MARKET FORECAST (2025-2033)
10.2 KANSAI/KINKI REGION
10.2.1 OVERVIEW
10.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.2.3 MARKET BREAKUP BY PRODUCT TYPE
10.2.4 MARKET BREAKUP BY TECHNOLOGY
10.2.5 KEY PLAYERS
10.2.6 MARKET FORECAST (2025-2033)
10.3 CENTRAL/ CHUBU REGION
10.3.1 OVERVIEW
10.3.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.3.3 MARKET BREAKUP BY PRODUCT TYPE
10.3.4 MARKET BREAKUP BY TECHNOLOGY
10.3.5 KEY PLAYERS
10.3.6 MARKET FORECAST (2025-2033)
10.4 KYUSHU-OKINAWA REGION
10.4.1 OVERVIEW
10.4.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.4.3 MARKET BREAKUP BY PRODUCT TYPE
10.4.4 MARKET BREAKUP BY TECHNOLOGY
10.4.5 KEY PLAYERS
10.4.6 MARKET FORECAST (2025-2033)
10.5 TOHOKU REGION
10.5.1 OVERVIEW
10.5.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.5.3 MARKET BREAKUP BY PRODUCT TYPE
10.5.4 MARKET BREAKUP BY TECHNOLOGY
10.5.5 KEY PLAYERS
10.5.6 MARKET FORECAST (2025-2033)
10.6 CHUGOKU REGION
10.6.1 OVERVIEW
10.6.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.6.3 MARKET BREAKUP BY PRODUCT TYPE
10.6.4 MARKET BREAKUP BY TECHNOLOGY
10.6.5 KEY PLAYERS
10.6.6 MARKET FORECAST (2025-2033)
10.7 HOKKAIDO REGION
10.7.1 OVERVIEW
10.7.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.7.3 MARKET BREAKUP BY PRODUCT TYPE
10.7.4 MARKET BREAKUP BY TECHNOLOGY
10.7.5 KEY PLAYERS
10.7.6 MARKET FORECAST (2025-2033)
10.8 SHIKOKU REGION
10.8.1 OVERVIEW
10.8.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
10.8.3 MARKET BREAKUP BY PRODUCT TYPE
10.8.4 MARKET BREAKUP BY TECHNOLOGY
10.8.5 KEY PLAYERS
10.8.6 MARKET FORECAST (2025-2033)
11 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET – COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET STRUCTURE
11.3 MARKET PLAYER POSITIONING
11.4 TOP WINNING STRATEGIES
11.5 COMPETITIVE DASHBOARD
11.6 COMPANY EVALUATION QUADRANT
12 PROFILES OF KEY PLAYERS
12.1 ABIOMED, INC.
12.1.1 BUSINESS OVERVIEW
12.1.2 PRODUCT PORTFOLIO
12.1.3 BUSINESS STRATEGIES
12.1.4 SWOT ANALYSIS
12.1.5 MAJOR NEWS AND EVENTS
12.2 ASAHI KASEI MEDICAL CO. LTD.
12.2.1 BUSINESS OVERVIEW
12.2.2 PRODUCT PORTFOLIO
12.2.3 BUSINESS STRATEGIES
12.2.4 SWOT ANALYSIS
12.2.5 MAJOR NEWS AND EVENTS
12.3 BAXTER INTERNATIONAL, INC.
12.3.1 BUSINESS OVERVIEW
12.3.2 PRODUCT PORTFOLIO
12.3.3 BUSINESS STRATEGIES
12.3.4 SWOT ANALYSIS
12.3.5 MAJOR NEWS AND EVENTS
12.4 BERLIN HEART GMBH
12.4.1 BUSINESS OVERVIEW
12.4.2 PRODUCT PORTFOLIO
12.4.3 BUSINESS STRATEGIES
12.4.4 SWOT ANALYSIS
12.4.5 MAJOR NEWS AND EVENTS
12.5 BOSTON SCIENTIFIC CORPORATION
12.5.1 BUSINESS OVERVIEW
12.5.2 PRODUCT PORTFOLIO
12.5.3 BUSINESS STRATEGIES
12.5.4 SWOT ANALYSIS
12.5.5 MAJOR NEWS AND EVENTS
12.6 COCHLEAR LIMITED
12.7 CYBERONICS INC.
12.8 CARL BENNET AB (GETINGE AB)
12.9 MEDTRONIC PLC
12.10 OSSUR HF.
12.11 HEARTWARE INTERNATIONAL, INC
12.12 ZIMMER BIOMET HOLDINGS, INC.
12.13 OTHERS
13 JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET - INDUSTRY ANALYSIS
13.1 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
13.1.1 OVERVIEW
13.1.2 DRIVERS
13.1.3 RESTRAINTS
13.1.4 OPPORTUNITIES
13.2 PORTERS FIVE FORCES ANALYSIS
13.2.1 OVERVIEW
13.2.2 BARGAINING POWER OF BUYERS
13.2.3 BARGAINING POWER OF SUPPLIERS
13.2.4 DEGREE OF COMPETITION
13.2.5 THREAT OF NEW ENTRANTS
13.2.6 THREAT OF SUBSTITUTES
13.3 VALUE CHAIN ANALYSIS
14 APPENDIX
著作権 ©2022 無断複写・転載を禁じます
